About MLBio Solutions & BridgeBio Pharma

ML Bio Solutions (ML Bio), a BridgeBio company, is a biotechnology company founded in 2018, yet the company’s founders have been dedicated to finding a cure for Limb girdle muscular dystrophy type 2I/R9 FKRP-related (LGMD2I/LGMDR9) for close to twenty years. ML Bio is developing BBP-418, potentially the first oral treatment for patients with LGMD2I.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas, including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.  
 
Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 
 
To learn more about our story and company culture, visit us at https://mlbiosolutions.com/ | https://bridgebio.com

Who You Are

Reporting to CMO Doug Sproule, the Director, Medical Affairs will be responsible for developing and executing the Medical Affairs strategy and serving as a strategic partner in the business, particularly with the clinical development and commercial teams. Equally important will be building and maintaining critical relationships in the medical and scientific communities. This field-based position will build healthcare provider support, leveraging a scientific approach aligned with medical affairs objectives and therapeutic area medical plan.

The individual will be responsible for cultivating and maintaining relationships with academic researchers, therapeutic area leaders, relevant research centers and organizations, attending conferences and presentations, and engaging in scientific exchange with physicians and other healthcare professionals. The Director, Medical Affairs will work closely with other functional leaders and support product development by translating insights, academic information, and congress interactions. They will strategically support the development, launch, and commercialization of BBP-418 through scientific exchange, seeking external insight to shape understanding of the therapeutic environment. This position will require frequent travel, sometimes involving weekends.

Responsibilities

• Ensure market readiness and drive the importance of the role of Medical in answering key scientific questions related to BBP-418
• Ensure high-quality and meaningful medical input for medical, scientific, and promotional documents, and in support of business development activities
• Proactively seek and create relationships directly with key opinion leaders, prominent clinical investigators, and scientific advisory groups in LGMD2I and beyond; providing them with credible, fair, balanced, scientific information about product development, research activities, and therapy(s)
• Be a significant source of balanced medical information for HCPs and will be skilled in issues management and addressing unsolicited questions about safety and potential off-label use of products based on available scientific data
• Oversee medical and scientific communications, including ensuring strong publication plans of clinical and real-world data to contribute to the scientific literature and support the commercialization and access of our medicines
• Liaise with key internal stakeholders to build a comprehensive action-oriented territory plan. This plan may be dynamic with respect to the molecule, molecule life-cycle, therapeutic area, and territory
• Expected to become a therapeutic area and product expert. This will be evidenced by regular review of relevant literature and participation in scientific congresses and conferences, including therapeutic area training sessions, to establish and maintain an up-to-date knowledge base
• Be instrumental in internal training and communication. Knowledge sharing, including KOL and site profiling, and education both internally and externally will be a crucial area of responsibility
• Assist CMO in identifying potential investigators and research projects. This may include assistance with the investigator-sponsored trial process, sponsored study site identification, recruitment strategies, and collaboration with clinical operations

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• Advanced healthcare degree, including PharmD, Ph.D., or MD, required

• Relevant Experience
• 5+ years of experience in the field of medical affairs
• Skills

• Entrepreneurial spirit who enjoys a hands-on, HCP-facing role
• Excellent interpersonal communication and presentation skills (including networking)
• Able to participate in a scientific dialogue with KOLs and researchers
• Excellent teaching skills and ability to present and discuss scientific material clearly and concisely
• Proven ability to create and sustain relationships with industry leaders
• Skilled in clinical research and an understanding of the process of pharmaceutical product development and approval
• Demonstrated ability to organize, prioritize and work effectively with minimal supervision in a constantly changing environment

• Travel – 50% time used for travel

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion